Section 1 - National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 17 of 1993) - National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 17 of 1993)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

No. PB 17 of 1993

I, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health, Housing, Local Government and Community Services and Delegate of the Minister for Health, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

This Declaration shall come into operation on 1 December 1993.
The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Amoxycillin Sodium

“Maxamum XP”

Rolitetracycline

Trioxysalen

Dated this fifteenth day of November 1993.

D. GRAHAM

Assistant Secretary

Pharmaceutical Benefits Branch

Department of Health, Housing, Local Government and Community Services

Delegate of the Minister for Health

1National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 17 of 1993)

Get a plain-English read of 1